Loading...
Please wait, while we are loading the content...
Similar Documents
Lambert-Eaton Myasthenic Syndrome
| Content Provider | Scilit |
|---|---|
| Author | Kesner, Vita G. Oh, Shin J. Dimachkie, Mazen M. Barohn, Richard J. |
| Copyright Year | 2018 |
| Description | Journal: Neurologic Clinics Lambert-Eaton myasthenic syndrome is a paraneoplastic or primary autoimmune neuromuscular junction disorder characterized by proximal weakness, autonomic dysfunction and ariflexia. The characteristic symptoms are thought to be caused by antibodies generated against the P/Q-type voltage-gated calcium channels present on presynaptic nerve terminals and by diminished release of acetylcholine. More than half of Lambert-Eaton myasthenic syndrome cases are associated with small cell lung carcinoma. Diagnosis is confirmed by serologic testing and electrophysiologic studies. 3,4-diaminopyridine is effective symptomatic treatment of LEMS. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690495/pdf |
| Ending Page | 394 |
| Page Count | 16 |
| Starting Page | 379 |
| ISSN | 07338619 |
| e-ISSN | 15579875 |
| DOI | 10.1016/j.ncl.2018.01.008 |
| Journal | Neurologic Clinics |
| Issue Number | 2 |
| Volume Number | 36 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2018-04-11 |
| Access Restriction | Open |
| Subject Keyword | Journal: Neurologic Clinics Lambert-eaton Myasthenic Syndrome Neuromuscular Transmission Disorder Paraneoplastic Syndrome P/q-type Voltage-gated Calcium Channels 4-diaminopyridine |
| Content Type | Text |
| Resource Type | Article |
| Subject | Neurology (clinical) |